It is imperative that new therapeutic options be evaluated to identify those that may
successfully circumvent chemoresistance in ovarian cancer and improve long-term …

Introdução: As mutações dos genes BRCA1 e BRCA2 representam um dos principais
fatores de risco genético para o desenvolvimento de cancro do ovário e da mama …

La anticoncepción hormonal combinada es un método anticonceptivo altamente eficaz que
actualmente sigue usándose poco a pesar de su seguridad y los beneficios que puede …

Epithelial ovarian cancer (EOC) is a heterogeneous disease with five histotypes: serous
(highgrade and low-grade), endometrioid, clear cell and mucinous carcinomas. New …

La anticoncepción hormonal combinada es un método anticonceptivo altamente eficaz que
actualmente sigue usándose poco a pesar de su seguridad y los beneficios que puede …

For patients with a known hereditary risk of ovarian cancer, primary prevention typically is
accomplished through prophylactic bilateral salpingo-oophorectomy. However, some …

In the UK, more than 50% have given formula by the time their babies are 6 weeks, and only
one in 200 will be breastfeeding by the time their baby is 1 year. The natural term of …

The authors have conducted a systematic analysis of the data available in modern literature
on the role of genetic testing for mutations in the genes responsible for a predisposition to …

Following the development of the lung-on-a-chip system there has been a rapid increase in
interest in advanced tissue culture models embedded in microfluidic systems. Some models …

Il cancro ovarico è la principale causa di morte tra le varie neoplasie ginecologiche; a livello
mondiale ogni anno viene diagnosticato a 240.000 donne e, con una sopravvivenza a …